<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32968195</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-3642</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>23</Day></PubDate></JournalIssue><Title>Communications biology</Title><ISOAbbreviation>Commun Biol</ISOAbbreviation></Journal><ArticleTitle>A multi-ethnic meta-analysis identifies novel genes, including ACSL5, associated with amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>526</StartPage><MedlinePgn>526</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">526</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42003-020-01251-2</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a devastating progressive motor neuron disease that affects people of all ethnicities. Approximately 90% of ALS cases are sporadic and thought to have multifactorial pathogenesis. To understand the genetics of sporadic ALS, we conducted a genome-wide association study using 1,173 sporadic ALS cases and 8,925 controls in a Japanese population. A combined meta-analysis of our Japanese cohort with individuals of European ancestry revealed a significant association at the ACSL5 locus (top SNP p&#x2009;=&#x2009;2.97&#x2009;&#xd7;&#x2009;10<sup>-8</sup>). We validated the association with ACSL5 in a replication study with a Chinese population and an independent Japanese population (1941 ALS cases, 3821 controls; top SNP p&#x2009;=&#x2009;1.82&#x2009;&#xd7;&#x2009;10<sup>-4</sup>). In the combined meta-analysis, the intronic ACSL5 SNP rs3736947 showed the strongest association (p&#x2009;=&#x2009;7.81&#x2009;&#xd7;&#x2009;10<sup>-11</sup>). Using a gene-based analysis of the full multi-ethnic dataset, we uncovered additional genes significantly associated with ALS: ERGIC1, RAPGEF5, FNBP1, and ATXN3. These results advance our understanding of the genetic basis of sporadic ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Nakamura</LastName><ForeName>Ryoichi</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4854-3579</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Misawa</LastName><ForeName>Kazuharu</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-6277-4330</Identifier><AffiliationInfo><Affiliation>Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genome Analysis, Institute of Biomedical Science, Kansai Medical University, Hirakata, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tohnai</LastName><ForeName>Genki</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Nakatochi</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1838-4837</Identifier><AffiliationInfo><Affiliation>Division of Data Science, Department of Nursing, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furuhashi</LastName><ForeName>Sho</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atsuta</LastName><ForeName>Naoki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayashi</LastName><ForeName>Naoki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokoi</LastName><ForeName>Daichi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Kakeyu-Misayama Rehabilitation Center Kakeyu Hospital, Ueda, Nagano, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Hazuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Hirohisa</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Brain and Mind Research Center, Nagoya University, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Fujita Health University, Toyoake, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsuno</LastName><ForeName>Masahisa</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9453-9311</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izumi</LastName><ForeName>Yuishin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanai</LastName><ForeName>Kazuaki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Fukushima Medical University School of Medicine, Fukushima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hattori</LastName><ForeName>Nobutaka</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morita</LastName><ForeName>Mitsuya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Internal Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taniguchi</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kano</LastName><ForeName>Osamu</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Internal Medicine, Toho University Faculty of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oda</LastName><ForeName>Masaya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Vihara Hananosato Hospital, Miyoshi, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibuya</LastName><ForeName>Kazumoto</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuwabara</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Naoki</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-8880-8554</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Tohoku University School of Medicine, Sendai, Miyagi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aoki</LastName><ForeName>Masashi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tohoku University School of Medicine, Sendai, Miyagi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohta</LastName><ForeName>Yasuyuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Okayama University Graduate School of Medicine, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamashita</LastName><ForeName>Toru</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3634-5679</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Okayama University Graduate School of Medicine, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abe</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Okayama University Graduate School of Medicine, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Rina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Higashinagoya National Hospital, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aiba</LastName><ForeName>Ikuko</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Higashinagoya National Hospital, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okamoto</LastName><ForeName>Koichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Geriatrics Research Institute and Hospital, Maebashi, Gunma, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mizoguchi</LastName><ForeName>Kouichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Shizuoka Medical Center, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>Kazuko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Neurology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okada</LastName><ForeName>Yohei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Aichi Medical University, Nagakute, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishihara</LastName><ForeName>Tomohiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onodera</LastName><ForeName>Osamu</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-3354-5472</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakashima</LastName><ForeName>Kenji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization, Matsue Medical Center, Matsue, Shimane, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaji</LastName><ForeName>Ryuji</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-6207-1080</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamatani</LastName><ForeName>Yoichiro</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-8748-5597</Identifier><AffiliationInfo><Affiliation>Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikegawa</LastName><ForeName>Shiro</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0316-2147</Identifier><AffiliationInfo><Affiliation>Laboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Momozawa</LastName><ForeName>Yukihide</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubo</LastName><ForeName>Michiaki</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0095-2322</Identifier><AffiliationInfo><Affiliation>RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishida</LastName><ForeName>Noriko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minegishi</LastName><ForeName>Naoko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagasaki</LastName><ForeName>Masao</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4292-8785</Identifier><AffiliationInfo><Affiliation>Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan. nagasaki@genome.med.kyoto-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Sakyo-ku, Kyoto, Japan. nagasaki@genome.med.kyoto-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan. nagasaki@genome.med.kyoto-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobue</LastName><ForeName>Gen</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-4769-5922</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. sobueg@aichi-med-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain and Mind Research Center, Nagoya University, Nagoya, Aichi, Japan. sobueg@aichi-med-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aichi Medical University, Nagakute, Aichi, Japan. sobueg@aichi-med-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Biol</MedlineTA><NlmUniqueID>101719179</NlmUniqueID><ISSNLinking>2399-3642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 6.2.1.-</RegistryNumber><NameOfSubstance UI="D003066">Coenzyme A Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.2.1.3</RegistryNumber><NameOfSubstance UI="C485465">ACSL5 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003066" MajorTopicYN="N">Coenzyme A Ligases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005796" MajorTopicYN="N">Genes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">White People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>24</Day><Hour>5</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32968195</ArticleId><ArticleId IdType="pmc">PMC7511394</ArticleId><ArticleId IdType="doi">10.1038/s42003-020-01251-2</ArticleId><ArticleId IdType="pii">10.1038/s42003-020-01251-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura R, et al. Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort. Neurobiol. Aging. 2016;39:219 e211&#x2013;218. doi: 10.1016/j.neurobiolaging.2015.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.11.030</ArticleId><ArticleId IdType="pubmed">26742954</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J. Neurol. Neurosurg. Psychiatry. 2010;81:1324&#x2013;1326. doi: 10.1136/jnnp.2010.207464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.207464</ArticleId><ArticleId IdType="pmc">PMC2988617</ArticleId><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1043&#x2013;1048. doi: 10.1038/ng.3622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3622</ArticleId><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson RE, et al. Genome-wide association studies in ancestrally diverse populations: Opportunities, methods, pitfalls, and recommendations. Cell. 2019;179:589&#x2013;603. doi: 10.1016/j.cell.2019.08.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.08.051</ArticleId><ArticleId IdType="pmc">PMC6939869</ArticleId><ArticleId IdType="pubmed">31607513</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1268&#x2013;1283 e1266. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Benyamin B, et al. Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis. Nat. Commun. 2017;8:611. doi: 10.1038/s41467-017-00471-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00471-1</ArticleId><ArticleId IdType="pmc">PMC5606989</ArticleId><ArticleId IdType="pubmed">28931804</ArticleId></ArticleIdList></Reference><Reference><Citation>GTEx Consortium. The genotype-tissue expression (GTEx) project. Nat. Genet. 2013;45:580&#x2013;585. doi: 10.1038/ng.2653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2653</ArticleId><ArticleId IdType="pmc">PMC4010069</ArticleId><ArticleId IdType="pubmed">23715323</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat. Genet. 2009;41:1083&#x2013;1087. doi: 10.1038/ng.442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.442</ArticleId><ArticleId IdType="pubmed">19734901</ArticleId></ArticleIdList></Reference><Reference><Citation>Batra, R. et al. Gene expression signatures of sporadic ALS motor neuron populations. Preprint at BioRxiv, https://www.biorxiv.org/content/10.1101/038448v2 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/038448v2</ArticleId></ArticleIdList></Reference><Reference><Citation>Krach F, et al. Transcriptome-pathology correlation identifies interplay between TDP-43 and the expression of its kinase CK1E in sporadic ALS. Acta Neuropathol. 2018;136:405&#x2013;423. doi: 10.1007/s00401-018-1870-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1870-7</ArticleId><ArticleId IdType="pmc">PMC6215775</ArticleId><ArticleId IdType="pubmed">29881994</ArticleId></ArticleIdList></Reference><Reference><Citation>Andres-Benito P, Moreno J, Aso E, Povedano M, Ferrer I. Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration. Aging (Albany NY) 2017;9:823&#x2013;851. doi: 10.18632/aging.101195.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101195</ArticleId><ArticleId IdType="pmc">PMC5391234</ArticleId><ArticleId IdType="pubmed">28283675</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita Y, et al. Fatty acid induced glioma cell growth is mediated by the acyl-CoA synthetase 5 gene located on chromosome 10q25.1-q25.2, a region frequently deleted in malignant gliomas. Oncogene. 2000;19:5919&#x2013;5925. doi: 10.1038/sj.onc.1203981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1203981</ArticleId><ArticleId IdType="pubmed">11127823</ArticleId></ArticleIdList></Reference><Reference><Citation>Klemens J, et al. Neurotoxic potential of reactive astrocytes in canine distemper demyelinating leukoencephalitis. Sci. Rep. 2019;9:11689. doi: 10.1038/s41598-019-48146-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48146-9</ArticleId><ArticleId IdType="pmc">PMC6690900</ArticleId><ArticleId IdType="pubmed">31406213</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481&#x2013;487. doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai M, et al. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat. Genet. 2018;50:390&#x2013;400. doi: 10.1038/s41588-018-0047-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0047-6</ArticleId><ArticleId IdType="pubmed">29403010</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, et al. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort. Ann. Neurol. 2017;81:718&#x2013;728. doi: 10.1002/ana.24936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24936</ArticleId><ArticleId IdType="pubmed">28437840</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng P, Zhou X. Causal effects of blood lipids on amyotrophic lateral sclerosis: a Mendelian randomization study. Hum. Mol. Genet. 2019;28:688&#x2013;697. doi: 10.1093/hmg/ddy384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy384</ArticleId><ArticleId IdType="pmc">PMC6360326</ArticleId><ArticleId IdType="pubmed">30445611</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve. 2011;44:20&#x2013;24. doi: 10.1002/mus.22114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22114</ArticleId><ArticleId IdType="pmc">PMC4441750</ArticleId><ArticleId IdType="pubmed">21607987</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S, et al. Long non coding RNAs and ALS: still much to do. Noncoding RNA Res. 2018;3:226&#x2013;231. doi: 10.1016/j.ncrna.2018.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncrna.2018.11.004</ArticleId><ArticleId IdType="pmc">PMC6260474</ArticleId><ArticleId IdType="pubmed">30533570</ArticleId></ArticleIdList></Reference><Reference><Citation>Breuza L, et al. Proteomics of endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membranes from brefeldin A-treated HepG2 cells identifies ERGIC-32, a new cycling protein that interacts with human Erv46. J. Biol. Chem. 2004;279:47242&#x2013;47253. doi: 10.1074/jbc.M406644200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M406644200</ArticleId><ArticleId IdType="pubmed">15308636</ArticleId></ArticleIdList></Reference><Reference><Citation>Soo KY, et al. Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS. Acta Neuropathol. 2015;130:679&#x2013;697. doi: 10.1007/s00401-015-1468-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1468-2</ArticleId><ArticleId IdType="pubmed">26298469</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, et al. Selective genetic overlap between amyotrophic lateral sclerosis and diseases of the frontotemporal dementia spectrum. JAMA Neurol. 2018;75:860&#x2013;875. doi: 10.1001/jamaneurol.2018.0372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.0372</ArticleId><ArticleId IdType="pmc">PMC6043387</ArticleId><ArticleId IdType="pubmed">29630712</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebhun JF, Castro AF, Quilliam LA. Identification of guanine nucleotide exchange factors (GEFs) for the Rap1 GTPase - Regulation of MR-GEF by M-Ras-GTP interaction. J. Biol. Chem. 2000;275:34901&#x2013;34908. doi: 10.1074/jbc.M005327200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M005327200</ArticleId><ArticleId IdType="pubmed">10934204</ArticleId></ArticleIdList></Reference><Reference><Citation>Bithell A, Alberta J, Hornby F, Stiles CD, Williams BP. Expression of the guanine nucleotide exchange factor, mr-gef, is regulated during the differentiation of specific subsets of telencephalic neurons. Dev. Brain Res. 2003;146:107&#x2013;118. doi: 10.1016/j.devbrainres.2003.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devbrainres.2003.09.017</ArticleId><ArticleId IdType="pubmed">14643017</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimada A, et al. Curved EFC/F-BAR-domain dimers are joined end to end into a filament for membrane invagination in endocytosis. Cell. 2007;129:761&#x2013;772. doi: 10.1016/j.cell.2007.03.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.03.040</ArticleId><ArticleId IdType="pubmed">17512409</ArticleId></ArticleIdList></Reference><Reference><Citation>Maximino JR, de Oliveira GP, Alves CJ, Chadi G. Deregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1(G93A) Amyotrophic Lateral Sclerosis mouse model. Front. Cell. Neurosci. 2014;8:148. doi: 10.3389/fncel.2014.00148.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00148</ArticleId><ArticleId IdType="pmc">PMC4033281</ArticleId><ArticleId IdType="pubmed">24904291</ArticleId></ArticleIdList></Reference><Reference><Citation>Evers MM, Toonen LJ, van Roon-Mom WM. Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies. Mol. Neurobiol. 2014;49:1513&#x2013;1531.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4012159</ArticleId><ArticleId IdType="pubmed">24293103</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawaguchi Y, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet. 1994;8:221&#x2013;228. doi: 10.1038/ng1194-221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1194-221</ArticleId><ArticleId IdType="pubmed">7874163</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CF, et al. Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph disease. Acta Neuropathol. 2009;118:553&#x2013;560. doi: 10.1007/s00401-009-0552-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0552-x</ArticleId><ArticleId IdType="pubmed">19526244</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden AC, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi N, et al. Prognosis of amyotrophic lateral sclerosis patients undergoing tracheostomy invasive ventilation therapy in Japan. J. Neurol. Neurosurg. Psychiatry. 2020;91:285&#x2013;290. doi: 10.1136/jnnp-2019-322213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322213</ArticleId><ArticleId IdType="pubmed">31937581</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozawa, A. et al. Study profile of The Tohoku Medical Megabank Community-Based Cohort Study. J. Epidemiol. 10.2188/jea.JE20190271 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7738642</ArticleId><ArticleId IdType="pubmed">31932529</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuriyama S, et al. The Tohoku Medical Megabank Project: Design and mission. J. Epidemiol. 2016;26:493&#x2013;511. doi: 10.2188/jea.JE20150268.</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20150268</ArticleId><ArticleId IdType="pmc">PMC5008970</ArticleId><ArticleId IdType="pubmed">27374138</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirata M, et al. Overview of BioBank Japan follow-up data in 32 diseases. J. Epidemiol. 2017;27:S22&#x2013;S28. doi: 10.1016/j.je.2016.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.je.2016.12.006</ArticleId><ArticleId IdType="pmc">PMC5363789</ArticleId><ArticleId IdType="pubmed">28190660</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai A, et al. Overview of the BioBank Japan Project: Study design and profile. J. Epidemiol. 2017;27:S2&#x2013;S8. doi: 10.1016/j.je.2016.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.je.2016.12.005</ArticleId><ArticleId IdType="pmc">PMC5350590</ArticleId><ArticleId IdType="pubmed">28189464</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Disease. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi-Kabata Y, et al. iJGVD: an integrative Japanese genome variation database based on whole-genome sequencing. Hum. Genome Var. 2015;2:15050. doi: 10.1038/hgv.2015.50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/hgv.2015.50</ArticleId><ArticleId IdType="pmc">PMC4785574</ArticleId><ArticleId IdType="pubmed">27081555</ArticleId></ArticleIdList></Reference><Reference><Citation>Bycroft C, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203&#x2013;209. doi: 10.1038/s41586-018-0579-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0579-z</ArticleId><ArticleId IdType="pmc">PMC6786975</ArticleId><ArticleId IdType="pubmed">30305743</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagasaki M, et al. Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals. Nat. Commun. 2015;6:8018. doi: 10.1038/ncomms9018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9018</ArticleId><ArticleId IdType="pmc">PMC4560751</ArticleId><ArticleId IdType="pubmed">26292667</ArticleId></ArticleIdList></Reference><Reference><Citation>Shido K, et al. Susceptibility loci for tanning ability in the Japanese population identified by a genome-wide association study from the Tohoku Medical Megabank Project Cohort Study. J. Invest. Dermatol. 2019;139:1605&#x2013;1608 e1613. doi: 10.1016/j.jid.2019.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jid.2019.01.015</ArticleId><ArticleId IdType="pubmed">30690034</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuttke M, et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat. Genet. 2019;51:957&#x2013;972. doi: 10.1038/s41588-019-0407-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0407-x</ArticleId><ArticleId IdType="pmc">PMC6698888</ArticleId><ArticleId IdType="pubmed">31152163</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellingson SR, Fardo DW. Automated quality control for genome wide association studies. F1000Res. 2016;5:1889. doi: 10.12688/f1000research.9271.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.9271.1</ArticleId><ArticleId IdType="pmc">PMC5007749</ArticleId><ArticleId IdType="pubmed">27635224</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson CA, et al. Data quality control in genetic case-control association studies. Nat. Protoc. 2010;5:1564&#x2013;1573. doi: 10.1038/nprot.2010.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2010.116</ArticleId><ArticleId IdType="pmc">PMC3025522</ArticleId><ArticleId IdType="pubmed">21085122</ArticleId></ArticleIdList></Reference><Reference><Citation>International League Against Epilepsy Consortium on Complex Epilepsies. Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies. Nat. Commun. 2018;9:5269. doi: 10.1038/s41467-018-07524-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07524-z</ArticleId><ArticleId IdType="pmc">PMC6288131</ArticleId><ArticleId IdType="pubmed">30531953</ArticleId></ArticleIdList></Reference><Reference><Citation>Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190&#x2013;2191. doi: 10.1093/bioinformatics/btq340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq340</ArticleId><ArticleId IdType="pmc">PMC2922887</ArticleId><ArticleId IdType="pubmed">20616382</ArticleId></ArticleIdList></Reference><Reference><Citation>Pruim RJ, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010;26:2336&#x2013;2337. doi: 10.1093/bioinformatics/btq419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq419</ArticleId><ArticleId IdType="pmc">PMC2935401</ArticleId><ArticleId IdType="pubmed">20634204</ArticleId></ArticleIdList></Reference><Reference><Citation>Momozawa Y, et al. Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population. Hum. Mol. Genet. 2016;25:5027&#x2013;5034.</Citation><ArticleIdList><ArticleId IdType="pubmed">28173125</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 2015;11:e1004219. doi: 10.1371/journal.pcbi.1004219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1004219</ArticleId><ArticleId IdType="pmc">PMC4401657</ArticleId><ArticleId IdType="pubmed">25885710</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu MC, et al. Rare-variant association testing for sequencing data with the sequence kernel association test. Am. J. Hum. Genet. 2011;89:82&#x2013;93. doi: 10.1016/j.ajhg.2011.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2011.05.029</ArticleId><ArticleId IdType="pmc">PMC3135811</ArticleId><ArticleId IdType="pubmed">21737059</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe H, et al. A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of TTN. J. Neurol. Neurosurg. Psychiatry. 2016;87:851&#x2013;858. doi: 10.1136/jnnp-2015-311541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311541</ArticleId><ArticleId IdType="pubmed">26746183</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>